PPARGC1A and melanoma: In accordance with shRNA-mediated knockdown, PGC1α had impaired proliferation and migration rates in glioblastoma cells.34 And in melanoma cells, a low level of PGC1α is more glycolytic, decreasing the proliferation and survival against ROS-induced apoptosis.35